Don’t Déjà Vu Me, Bro


“What we’re seeing is just like what happened with opioids in the 1990s.”

~ Dr. Anna Lembke, researcher and addiction specialist at
Stanford University


I’m linking to an article from Stateline/The Pew Charitable Trusts by Christine Vestal, that sounds the alarm about abuses of anti-anxiety medications such as Valium, Xanax and Klonopin (benzodiazepines). They are widely prescribed, relatively inexpensive, and many providers consider them safe and non-addictive.


Forgive me if I tell you I have heard this before. The prescribing of these medications has increased dramatically over the last 20 years. Now state and federal regulators are warning the public about:


  • Excessive prescribing;
  • Addiction and dependence risks;
  • Dangers when used in combination with alcohol and painkillers.


According to the National Institute on Drug Abuse, “More than 30 percent of overdoses involving opioids also involve benzodiazepines.”


As industry stakeholders:

  • We must be vigilant;
  • We must apply the science;
  • We must do better this time.


Call us. We can do better.

William Faris, JD
Chief Executive Officer

Posted in Medical Cost Containment, OMCA, Workers’ Compensation